High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05585151

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05585151
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05585151. Randomized; no masking; primary purpose treatment. Start 2022-11-09 (actual); primary completion 2024-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
Condition
Cerebral Atherosclerosis
Intervention (Drug)
Evolocumab 140 MG/ML
Intervention (Drug)
Intensive statin treatment
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)

Record details

Record id
cardio:ct-nct05585151
Content hash
f3a0f351bc573b596141c5e083ac54bb861e7f206b5f0d1ea81e8b9fb87632c3